ArticleLiver research (Beijing, China)2022

Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression.

Wenchao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.